-
OFF-LABEL USE AND ADHERENCE TO GLP-1S AS ADJUNCT THERAPY IN TYPE 1 DIABETES: A COMPARATIVE ANALYSIS VERSUS METFORMIN
Mar 18, 2026, 21:38 PM -
ANALYSING THE IMPACT OF SHARED DECISION MAKING AMONGST CANCER PATIENTS ON TOTAL MEDICAL EXPENDITURE BY PAYER TYPE AND NUMBER OF EMERGENCY VISITS
Mar 18, 2026, 21:38 PM -
POTENTIAL BENEFITS OF RSV VACCINATION IN COLOMBIAN ADULTS AGED 60 AND OVER: A COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
META-ANALYSIS OF QUALITY OF LIFE AMONG PATIENTS WITH HEPATITIS C WITH OR WITHOUT SUSTAINED VIROLOGICAL RESPONSE
Mar 18, 2026, 21:38 PM -
ALTERNATIVE PAYMENT MODELS IN CARDIOLOGY: A SCOPING REVIEW OF DESIGN FEATURES, QUALITY OUTCOMES, AND COSTS
Mar 18, 2026, 21:38 PM -
THE BUDGET IMPACT OF INTRODUCING ZONGERTINIB INTO THE FORMULARY FOR TREATMENT-NAÏVE AND PRETREATED HER2-MUTANT ADVANCED NSCLC IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS WITH REAL-WORLD DATA REUSING BRAZILIAN HEALTH SYSTEM DATABASES: A CASE STUDY IN BREAST CANCER
Mar 18, 2026, 21:38 PM -
HEALTHCARE COST, RESOURCE USE, AND ECONOMIC MODELS OF CISPLATIN-INELIGIBLE MUSCLE-INVASIVE BLADDER CANCER PATIENTS (MIBC)
Mar 18, 2026, 21:38 PM -
ARE EVIDENCE REVIEW REQUIREMENTS SIMILAR ACROSS HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES? A CROSS-SECTIONAL STUDY OF NICE, CDA, IQWIG AND EU JCA
Mar 18, 2026, 21:38 PM -
SURVIVING UNANCHORED INDIRECT COMPARISONS: AN EXTENSION OF MULTILEVEL UNANCHORED META-REGRESSION (ML-UMR) FOR SURVIVAL ANALYSES
Mar 18, 2026, 21:38 PM -
TRENDS IN THE USE OF REAL-WORLD EVIDENCE IN PRESS RELEASES ISSUED BY THE TOP 15 PHARMACEUTICAL COMPANIES
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT OF FINERENONE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) AND HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION (HFMREF):IMPLICATIONS FOR U.S. HEALTHCARE DECISION-MAKERS
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A COMPOSITE ENDPOINT IN HYPOPHOSPHATASIA TO OPTIMIZE COST-EFFECTIVENESS DEMONSTRATION
Mar 18, 2026, 21:38 PM -
UNDERSTANDING CEA CHARACTERISTICS ASSOCIATED WITH COST-SAVING FINDINGS
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND VALIDATION OF AN ALGORITHM TO IDENTIFY ASPIRIN USE FROM ELECTRONIC MEDICAL RECORDS AND CLAIMS DATA
Mar 18, 2026, 21:38 PM -
AFFORDABILITY OF PEDIATRIC DRUGS THROUGH CHINA’S NATIONAL DRUG PRICE NEGOTIATION: 2017-2024
Mar 18, 2026, 21:38 PM -
EMPIRICAL TIME-SERIES ANALYSES IN THE PAST THREE DECADES 1991-2023 FOR IMMUNE THROMBOCYTOPENIA MEDICATIONS IN THE US MEDICAID PROGRAMS
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF VASOMOTOR SYMPTOMS AND DEPRESSION ON HEALTHCARE EXPENDITURES AMONG U.S. WOMEN
Mar 18, 2026, 21:38 PM -
TEST-RETEST RELIABILITY OF CASE 1 BEST-WORST SCALING: EVIDENCE FROM RELATIVE ATTRIBUTE IMPORTANCE OF PREFERENCES FOR AI USE IN HEALTHCARE
Mar 18, 2026, 21:38 PM -
LONGITUDINAL ASSOCIATIONS OF CHEMOTHERAPY INDUCED SYMPTOM CLUSTERS WITH HEALTHCARE UTILIZATION AND MORTALITY AMONG PATIENTS WITH GASTROINTESTINAL CANCERS
Mar 18, 2026, 21:38 PM
